First-line doxorubicin and high-dose ifosfamide (DHI) in advanced soft tissue sarcoma (STS) patients. A phase II study of the Spanish Group for Research on Sarcomas (GEIS)

被引：0
|
作者：
Lopez-Pousa, A [1 ]
Montalar, J [1 ]
Buesa, J [1 ]
Maurel, J [1 ]
Martin, J [1 ]
Cassinello, J [1 ]
Sevilla, I [1 ]
de las Penas, R [1 ]
Cruz, J [1 ]
Balana, C [1 ]
机构：
[1] Hosp Sant Pau, Spanish Grp Res Sarcomas, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
564P
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [1] Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: A study of the Spanish Group for Research on Sarcomas (GEIS)
    Buesa, JM
    Lopez-Pousa, A
    Martin, J
    Anton, A
    del Muro, JG
    Bellmunt, J
    Arranz, F
    Valenti, V
    Escudero, P
    Menendez, D
    Casado, A
    Poveda, A
    ANNALS OF ONCOLOGY, 1998, 9 (08) : 871 - 876
  • [2] High-dose ifosfamide and doxorrubicin (HDI-DX) in advanced previously untreated soft tissue sarcoma (STS) patients.: A phase II study of the Spanish group for research on sarcomas (GEIS).
    Pousa, AL
    Buesa, JM
    Montalar, J
    Martín, J
    Maurel, J
    del Muro, JG
    de las Peñas, R
    Cruz, J
    Cassinello, J
    Sevilla, I
    Balaña, C
    Casado, A
    Bover, I
    Paredes, A
    Carles, J
    Poveda, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S88 - S88
  • [3] Activity of doxorubicin after high-dose ifosfamide in adult patients with advanced soft tissue sarcoma: A study of the Spanish Group for Research on Sarcomas (GEIS)
    Buesa, JM
    Fra, J
    Anton, A
    Lopez-Pousa, A
    Martin, J
    del Muro, JG
    Escudero, P
    Casado, A
    Poveda, A
    ANNALS OF ONCOLOGY, 1998, 9 (07) : 783 - 785
  • [4] Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas -: A phase II trial by the Spanish Group for Research on Sarcomas (GEIS)
    Maurel, J
    Fra, J
    López-Pousa, A
    del Muro, XG
    Balañá, C
    Casado, A
    Martín, J
    Martínez-Trufero, J
    de las Peñas, R
    Buesa, JM
    CANCER, 2004, 100 (07) : 1498 - 1506
  • [5] Doxorubicin (DXR) and prolonged infusion gemcitabine (GMC) as first-line treatment in advanced soft tissue sarcomas (STS).: A phase II trial of the Spanish Group for Research in Sarcomas (GEIS).
    Lopez-Pousa, A
    Buesa, J
    Casado, A
    Del Muro, JG
    Poveda, A
    Maurel, J
    Martin, J
    Balaña, C
    Martinez, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 826S - 826S
  • [6] Phase II trial of ifosfamide in combination with sorafenib in patients with advanced soft tissue sarcoma: A Spanish Group for Research on Sarcomas (GEIS) study.
    Garcia del Muro, Xavier
    Maurel, Joan
    Martinez Trufero, Javier
    Lavernia, Javier
    Lopez-Pousa, Antonio
    De Las Penas, Ramon
    Cubedo, Ricardo
    Fra, Joaquin
    Casado, Antonio
    De Juan, Ana
    Jimenez Colomo, Laura
    Martin Broto, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Phase II trial of first-line high-dose ifosfamide in advanced adult soft tissue sarcoma
    Trarbach, T
    Scheulen, ME
    Schroder, J
    Stuschke, M
    Seeber, S
    Schutte, J
    TUMORDIAGNOSTIK & THERAPIE, 1997, 18 (02) : 57 - 60
  • [8] Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study
    Martin-Broto, Javier
    Lopez Pousa, Antonio
    de las Penas, Ramon
    Garcia del Muro, Xavier
    Gutierrez, Antonio
    Martinez-Trufero, Javier
    Cruz, Josefina
    Alvarez, Rosa
    Cubedo, Ricardo
    Redondo, Andres
    Maurel, Joan
    Carrasco, Juan A.
    Lopez-Martin, Jose A.
    Sala, Angeles
    Andres Meana, Jose
    Ramos, Rafael
    Martinez-Serra, Jordi
    Lopez-Guerrero, Jose A.
    Sevilla, Isabel
    Balana, Carmen
    Vaz, Angeles
    De Juan, Ana
    Alemany, Regina
    Poveda, Andres
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (19) : 2294 - +
  • [9] Phase II study of neoadjuvant high-dose ifosfamide with concurrent radiotherapy followed by surgical resection in high -risk soft tissue sarcoma: A Spanish Group for Research on Sarcomas (GEIS) study
    Garcia del Muro, Xavier
    Lopez-Pousa, Antonio
    Jose Flor, Maria
    Redondo, Andres
    Cruz Jurado, Josefina
    Andres, Raquel
    Casado, Antonio
    Fra, Joaquin
    Lopez-Martin, Jose A.
    Maurel, Juan
    Maria Valverde, Claudia
    Gallego, Oscar
    Antonio Narvaez, Jose
    Bague, Silvia
    Sanjuan, Xavier
    Vinyals, Juan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) study
    Xavier García del Muro
    Joan Maurel
    Javier Martínez Trufero
    Javier Lavernia
    Antonio López Pousa
    Ramón de las Peñas
    Ricardo Cubedo
    José Pablo Berros
    Antonio Casado Herráez
    Ana de Juan
    Javier Martín Broto
    Investigational New Drugs, 2018, 36 : 468 - 475
12345